Oshima K, Hirano H, Shoji H, Iwasa S, et al. Influence of precedent drug on the subsequent therapy in the sequence of trifluridine/tipiracil with/out bevacizumab and regorafenib for unresectable or recurrent colorectal cancer. PLoS One 2022;17:e0269115.
PMID: 35653412